Return to search

Palvella Therapeutics rakes in $45m Series C

Wayne, Pennsylvania-based Palvella Therapeutics Inc., a rare disease biopharmaceutical company, has raised $45 million in Series C financing.

Wayne, Pennsylvania-based Palvella Therapeutics Inc., a rare disease biopharmaceutical company, has raised $45 million in Series C financing. The backers included CAM Capital, Samsara BioCapital, BVF Partners L.P., Adams Street Partners, Opaleye Management, Ligand Pharmaceuticals, Agent Capital, BioAdvance and Nolan Capital.

Source: Press Release